<html xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:dt="uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=ProgId content=OneNote.File>
<meta name=Generator content="Microsoft OneNote 15">
<link id=Main-File rel=Main-File href=946001bf6a2e4c999bcf4c02e5af2c44.htm>
<link rel=File-List href="946001bf6a2e4c999bcf4c02e5af2c44.files/filelist.xml">
</head>

<body lang=zh-TW style='font-family:Calibri;font-size:11.0pt'>

<div style='direction:ltr;border-width:100%'>

<div style='direction:ltr;margin-top:0in;margin-left:0in;width:6.8423in'>

<div style='direction:ltr;margin-top:0in;margin-left:.3368in;width:6.5055in'>

<p style='margin:0in;font-family:"Microsoft JhengHei Light";font-size:20.0pt'
lang=en-GB>周邊動脈阻塞性疾病(Peripheral artery occlusion disease, PAOD) </p>

</div>

<div style='direction:ltr;margin-top:.0388in;margin-left:.3368in;width:1.5444in'>

<p style='margin:0in;font-family:Calibri;font-size:10.0pt;color:#666666'
lang=en-GB>07 April 2025</p>

<p style='margin:0in;font-family:Calibri;font-size:10.0pt;color:#666666'
lang=en-GB>11:59</p>

</div>

<div style='direction:ltr;margin-top:.0569in;margin-left:0in;width:6.5923in'>

<ul style='direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:0in'>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#244061'
      lang=en-US><span style='font-family:微軟正黑體;font-size:16.0pt'>定義</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
       lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>周邊動脈因</span><span
       style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>動脈粥狀硬化</span><span
       style='font-family:微軟正黑體;font-size:11.0pt;color:black'>而狹窄，</span><span
       style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>最常見於下肢動脈</span></li>
  </ul>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:微軟正黑體;font-size:11.0pt'>頸動脈狹窄（Carotid artery
       stenosis）和慢性腸繫膜缺血（chronic mesenteric ischemia）則較少見</span></li>
  </ul>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#244061'
      lang=en-US><span style='font-family:微軟正黑體;font-size:16.0pt'>流行病學</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
       lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>盛行率隨年齡上升</span><span
       style='font-family:微軟正黑體;font-size:11.0pt;color:black'>，</span><span
       style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>從 40 歲起開始明顯增加</span></li>
  </ul>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>種族</span><span style='font-family:微軟正黑體;font-size:
       11.0pt;color:black'>：</span><span style='font-family:微軟正黑體;font-size:
       11.0pt;color:#C00000'>非裔美國人（African American）</span><span
       style='font-family:微軟正黑體;font-size:11.0pt;color:black'>的發生率最高，其次為</span><span
       style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>西語裔（Hispanic）和非西語裔的白人（non-Hispanic
       White）</span></li>
  </ul>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>發病年齡高峰</span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:black'>：介於 </span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:#C00000'>60–80 歲</span><span style='font-family:
       微軟正黑體;font-size:11.0pt;color:black'>之間</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:微軟正黑體;font-size:11.0pt'>&gt; 69 歲：14.5%</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:"Microsoft JhengHei Light";font-size:11.0pt'>≥</span><span
        style='font-family:微軟正黑體;font-size:11.0pt'> 80 歲以上： 20%</span></li>
   </ul>
  </ul>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
       lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>男女比例相近（1：1）</span></li>
  </ul>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:微軟正黑體;font-size:11.0pt'>低收入和中等收入國家（</span><span
       style='font-family:"Segoe UI Symbol";font-size:11.0pt'>⭡</span><span
       style='font-family:微軟正黑體;font-size:11.0pt'>28.7%) 的增長比高收入國家（</span><span
       style='font-family:"Segoe UI Symbol";font-size:11.0pt'>⭡</span><span
       style='font-family:微軟正黑體;font-size:11.0pt'>13.1%）更為顯著</span></li>
  </ul>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#244061'
      lang=en-US><span style='font-family:微軟正黑體;font-size:16.0pt'>分類</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
       lang=en-US><span style='font-family:微軟正黑體;font-size:14.0pt'>臨床分類</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>無症狀（Asymptomatic）</span><span style='font-family:
        微軟正黑體;font-size:11.0pt;color:black'>：有血管狹窄/阻塞的發現，但病患</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>無典型症狀</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>慢性有症狀（Chronic symptomatic）</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>間歇性跛行（intermittent
        claudication）</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>慢性肢體威脅性缺血（Chronic limb-threatening ischemia, CLTI）</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>症狀持續超過2週</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt'>休息時疼痛（rest pain）</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt'>下肢傷口無法癒合</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt'>壞疽（gangrene）</span></li>
    </ul>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>急性肢體缺血（Acute limb ischemia, ALI）</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：動脈阻塞導致</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>肢體灌流急速下降</span></li>
   </ul>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
       lang=en-US><span style='font-family:微軟正黑體;font-size:14.0pt'>WIfI
       Classification（Wound, Ischemia, foot Infection）</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>用來量化PAD的嚴重程度，</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>預測截肢風險</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:black'>，並評估重建血管的潛在效益與風險</span></li>
   </ul>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>評分項目</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt;color:black'>Wound</span><span style='font-family:微軟正黑體;
         font-size:11.0pt;color:black'>：潰瘍的深度與組織影響程度</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt;color:black'>Ischemia</span><span style='font-family:微軟正黑體;
         font-size:11.0pt;color:black'>：踝部收縮壓、組織氧合情況</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt;color:black'>Foot Infection</span><span style='font-family:
         微軟正黑體;font-size:11.0pt;color:black'>：局部或全身感染徵象</span></li>
    </ul>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>各項目評分</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:black'>：</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:#C00000'>0-3分</span><span style='font-family:
        微軟正黑體;font-size:11.0pt;color:black'>（正常-嚴重） </span></li>
   </ul>
  </ul>
 </ul>
 <p style='margin:0in;margin-left:.75in'><img
 src="946001bf6a2e4c999bcf4c02e5af2c44_asset_0.png" width=480
 height=237></p>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
      lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>根據
      2019 systemic review and meta-analysis 顯示</span></li>
  <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>不同期別 1 年內截肢率</span></li>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>Stage I</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:black'>：</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:#C00000'>0%</span></li>
   </ul>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>Stage II</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:black'>：8%</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>Stage III</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:black'>：11%</span></li>
   </ul>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>Stage IV</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:black'>：</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:#C00000'>38%</span></li>
   </ul>
  </ul>
 </ul>
 <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
      lang=en-US><span style='font-family:微軟正黑體;font-size:14.0pt'>Fontaine
      Classification</span></li>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:微軟正黑體;font-size:11.0pt'>用於分期 PAD 的臨床嚴重程度</span></li>
  </ul>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>Stage I</span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:black'>： </span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:#C00000'>無症狀（asymptomatic）</span></li>
  </ul>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>Stage II</span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:black'>： </span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:#C00000'>運動時疼痛（pain on exertion）</span></li>
   <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>IIa</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:black'>：</span><span style='font-weight:bold;
        font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>mild claudication</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>IIb</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:black'>：</span><span style='font-weight:bold;
        font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>severe claudication</span></li>
   </ul>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>Stage III</span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:black'>： </span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:#C00000'>休息時疼痛（pain at rest）</span></li>
  </ul>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>Stage IV</span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:black'>：</span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:#C00000'>壞死（necrosis）、壞疽（gangrene）</span></li>
  </ul>
 </ul>
 <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
      lang=en-US><span style='font-family:微軟正黑體;font-size:14.0pt'>Rutherford
      Classification</span></li>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
       lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>共有</span><span
       style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>四個 Grade（0-III）</span><span
       style='font-family:微軟正黑體;font-size:11.0pt;color:black'>和 </span><span
       style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>七個Category（0-6）</span></li>
  </ul>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>無症狀（asymptomatic）</span><span style='font-family:
       微軟正黑體;font-size:11.0pt;color:black'>：</span><span style='font-family:
       微軟正黑體;font-size:11.0pt;color:#C00000'>Grade 0</span></li>
  </ul>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>跛行（claudication）</span><span style='font-family:
       微軟正黑體;font-size:11.0pt;color:black'>：</span><span style='font-family:
       微軟正黑體;font-size:11.0pt;color:#C00000'>Grade I </span></li>
   <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>根據</span><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>症狀的嚴重程度分為
        Category 1-3</span></li>
   </ul>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>休息時疼痛</span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:black'>：</span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:#C00000'>Grade II </span><span style='font-family:
       微軟正黑體;font-size:11.0pt;color:black'>、Catergory 4</span></li>
  </ul>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>有組織缺損（tissue loss）</span><span style='font-family:
       微軟正黑體;font-size:11.0pt;color:black'>：</span><span style='font-family:
       微軟正黑體;font-size:11.0pt;color:#C00000'>Grade III </span></li>
   <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>依據</span><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>組織缺損的嚴重程度分為
        Catergory 5-6 </span></li>
   </ul>
  </ul>
 </ul>
 <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
      lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
      11.0pt;color:black'>其他分類系統</span></li>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>TransAtlantic Inter-Society Consensus（TASC）</span><span
       style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：舊的分級</span></li>
   <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>評估</span><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>股膕動脈（femoropopliteal)
        和膕下動脈（infrapopliteal）</span><span style='font-family:微軟正黑體;font-size:
        11.0pt;color:black'>病變，根據病灶形態分為</span><span style='font-weight:bold;
        font-family:微軟正黑體;font-size:11.0pt;color:#F79646'> A、B、C、D 型</span></li>
   </ul>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>Global Limb Anatomic Staging System（GLASS）</span><span
       style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：逐漸取代TASC</span></li>
   <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>利用血管攝影（angiography）評估</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>股膕動脈（femoropopliteal)
        和膕下動脈（infrapopliteal）</span></li>
   </ul>
   <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>依照狹窄或阻塞的長度及其他特徵（如是否涉及血管起始處、是否有明顯鈣化等）來評分，分為</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>0-4分</span></li>
   </ul>
   <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>再綜合兩個評分，分為</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>三級（Stage
        I-III）</span><span style='font-family:微軟正黑體;font-size:11.0pt;
        color:black'>，可</span><span style='font-family:微軟正黑體;font-size:11.0pt;
        color:#C00000'>預測治療後血管通暢率與結果</span></li>
   </ul>
  </ul>
 </ul>
 <p style='margin:0in;margin-left:1.125in'><img
 src="946001bf6a2e4c999bcf4c02e5af2c44_asset_1.png" width=468
 height=221></p>
 <p style='margin:0in;margin-left:1.125in;font-family:微軟正黑體;font-size:9.0pt'
 lang=en-US>(Reference：Table 5.3, Global Vascular Guidelines on the Management
 of Chronic Limb-Threatening Ischemia. Eur J Vasc Endovasc Surg. 2019 Jul)</p>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
      lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
      11.0pt;color:black'>Angiosome Classification</span></li>
 </ul>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#244061'
      lang=en-US><span style='font-family:微軟正黑體;font-size:16.0pt'>病因</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
       lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>動脈粥樣硬化（atherosclerosis）</span></li>
  </ul>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>危險因子</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:#C00000'>吸煙</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:black'>：重要的危險因子之一</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
         style='font-family:微軟正黑體;font-size:11.0pt'>吸煙程度與 PAD 嚴重程度相關</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
         style='font-family:微軟正黑體;font-size:11.0pt'>應建議所有患者戒煙。</span></li>
    </ul>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:#C00000'>糖尿病</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:black'>：重要的危險因子之一，近年越來越多</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>患者容易發生</span><span
         style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>足部潰瘍和
         CLTI</span><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>，病變範圍和</span><span
         style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>嚴重程度與血糖控制相關</span></li>
    </ul>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#C00000'
        lang=en-US>年齡 </span><span style='font-weight:bold;font-family:"Microsoft JhengHei Light";
        font-size:11.0pt;color:#C00000' lang="x-IV_mathan">≥</span><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#C00000'
        lang=en-US> 75 歲</span><span style='font-family:微軟正黑體;font-size:11.0pt;
        color:black' lang=en-US>：主要危險因子</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>最常見於
         50 歲以上患者，且</span><span style='font-weight:bold;font-family:微軟正黑體;
         font-size:11.0pt;color:#F79646'>從 60 歲起，其盛行率大幅增加</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
         style='font-family:微軟正黑體;font-size:11.0pt'>69 歲以上患者的 PAD 盛行率為 14.5%，而
         80 歲以上的患者則可高達 20%</span></li>
    </ul>
   </ul>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>末期腎病（End-stage
        renal disease, ESRD）</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>抑鬱症</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt'>兩個或以上的區域出現粥狀動脈硬化（Atherosclerotic cardiovascular disease, ASCVD）
        </span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt'>周邊動脈、冠狀動脈和/或腦血管動脈</span></li>
    </ul>
   </ul>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>微血管疾病</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：視網膜病變、神經病變</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>高血壓、高血脂症</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>肥胖、久坐不動</span></li>
   </ul>
  </ul>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#244061'
      lang=en-US><span style='font-family:微軟正黑體;font-size:16.0pt'>病生理</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-family:微軟正黑體;font-size:11.0pt'>主動脈與周邊動脈的動脈粥狀硬化 → 動脈腔變窄 →
       阻塞導致遠端組織灌流不足 → PAD </span></li>
  </ul>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#244061'
      lang=en-US><span style='font-family:微軟正黑體;font-size:16.0pt'>臨床表現</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>無症狀：</span><span style='font-weight:bold;font-family:
       微軟正黑體;font-size:11.0pt;color:#F79646'>20-50% 的 PAD 患者無症狀</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:#C00000'>間歇性跛行（claudication）</span><span style='font-weight:
       bold;font-family:微軟正黑體;font-size:11.0pt;color:black'>：10-35%</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>表現為</span><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>疼痛、痙攣、或感覺異常（麻）</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:微軟正黑體;font-size:11.0pt'>常發生於動脈阻塞處的遠端</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>活動時加重，休息或將患肢垂下時緩解</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:black'>（通常在</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'> 10 分鐘內</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:black'>即緩解）</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:微軟正黑體;font-size:11.0pt'>根據阻塞部位不同，會有不同的臨床表現</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt;color:black'>股膕動脈病變（Femoropopliteal disease）</span><span
         style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：</span><span
         style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>最常見</span></li>
     <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
      margin-bottom:0in'>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
          lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;
          font-size:11.0pt;color:#F79646'>小腿跛行痛（calf claudication）</span></li>
     </ul>
    </ul>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt;color:black'>主髂動脈病變（Aortoiliac disease）</span><span
         style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：又稱 </span><span
         style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>Leriche
         syndrome</span></li>
     <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
      margin-bottom:0in'>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
          lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;
          color:black'>阻塞位於</span><span style='font-family:微軟正黑體;font-size:
          11.0pt;color:#C00000'>主動脈分叉處或雙側髂動脈</span></li>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;
          font-size:11.0pt'>Triad</span></li>
      <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
       margin-bottom:0in'>
       <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
           color:#C00000' lang=en-US><span style='font-family:微軟正黑體;font-size:
           11.0pt'>雙側臀部（buttock）、髖部（hip）、大腿跛行疼痛</span></li>
       <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
           color:#C00000' lang=en-US><span style='font-family:微軟正黑體;font-size:
           11.0pt'>勃起功能障礙（erectile dysfunction）</span></li>
       <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
           color:#C00000' lang=en-US><span style='font-family:微軟正黑體;font-size:
           11.0pt'>股動脈脈搏減弱或消失</span></li>
      </ul>
     </ul>
    </ul>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
         style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>膕下動脈病變（Infrapopliteal
         disease）</span></li>
     <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
      margin-bottom:0in'>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
          lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;
          font-size:11.0pt'>足部跛行痛（foot claudication）</span></li>
     </ul>
    </ul>
   </ul>
  </ul>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt'>Rest pain</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>疾病進展至</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>嚴重缺血階段</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:black'>的表現</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>通常先發生在</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>腳趾和前足</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:black'>（toes and
        forefoot）</span></li>
   </ul>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>平躺時加重
        (睡覺)，垂腳或站立時緩解</span></li>
   </ul>
  </ul>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>其他症狀</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:微軟正黑體;font-size:11.0pt'>有些病患主訴不是典型跛行，而是</span><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>下肢功能障礙</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt'>行走困難，需</span><span style='font-weight:bold;text-decoration:
         underline;font-family:微軟正黑體;font-size:11.0pt'>休息超過 10 分鐘</span><span
         style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>才能緩解</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt'>無痛性的腿部無力、麻木或疲勞</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt'>勃起功能障礙</span></li>
    </ul>
   </ul>
  </ul>
 </ul>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
      lang=en-US><span style='font-family:微軟正黑體;font-size:16.0pt;color:#244061'>診斷</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
       lang=en-US><span style='font-family:微軟正黑體;font-size:16.0pt;color:#244061'>Physical
       Examination</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>下肢病灶</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>傷口難以癒合或癒合緩慢</span><span
         style='font-family:微軟正黑體;font-size:11.0pt;color:black'>（Nonhealing or
         slow-healing wounds）</span></li>
     <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
      margin-bottom:0in'>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
          lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;
          font-size:11.0pt'>動脈性潰瘍（arterial ulcers）</span></li>
      <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
       margin-bottom:0in'>
       <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
           color:#C00000' lang=en-US><span style='font-weight:bold;font-family:
           微軟正黑體;font-size:11.0pt;color:black'>臨床表現</span></li>
       <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
        margin-bottom:0in'>
        <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
            color:#F79646' lang=en-US><span style='font-family:微軟正黑體;
            font-size:11.0pt;color:black'>邊緣清楚、</span><span style='font-weight:
            bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>Punched-out
            ulcer</span></li>
        <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
            color:#F79646' lang=en-US><span style='font-family:微軟正黑體;
            font-size:11.0pt;color:#F79646'>好發於</span><span style='font-weight:
            bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>足部</span><span
            style='font-family:微軟正黑體;font-size:11.0pt;color:black'>，特別是</span><span
            style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;
            color:#F79646'>壓力點</span><span style='font-family:微軟正黑體;font-size:
            11.0pt;color:black'>（如</span><span style='font-weight:bold;
            font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>外踝lateral
            malleolus、趾尖</span><span style='font-family:微軟正黑體;font-size:11.0pt;
            color:black'>）</span></li>
        <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
            color:#F79646' lang=en-US><span style='font-family:微軟正黑體;
            font-size:11.0pt;color:black'>伴隨劇烈疼痛，若傷口感染可能導致敗血症</span></li>
       </ul>
      </ul>
     </ul>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt;color:#C00000'>壞疽性壞死（Gangrenous necrosis）</span><span
         style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：分</span><span
         style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>濕性（wet）、乾性（dry）</span><span
         style='font-family:微軟正黑體;font-size:11.0pt;color:black'>壞疽</span></li>
     <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
      margin-bottom:0in'>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;
          font-size:11.0pt'>乾性壞疽（Dry gangrene）</span></li>
      <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
       margin-bottom:0in'>
       <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
           color:#F79646' lang=en-US><span style='font-family:微軟正黑體;font-size:
           11.0pt;color:black'>因</span><span style='font-family:微軟正黑體;
           font-size:11.0pt;color:#C00000'>缺血（ischemia）</span><span
           style='font-family:微軟正黑體;font-size:11.0pt;color:black'>導致的壞死，病理表現為</span><span
           style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>凝固性壞死</span><span
           style='font-family:微軟正黑體;font-size:11.0pt;color:black'>（coagulative
           necrosis）</span></li>
      </ul>
      <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
       margin-bottom:0in'>
       <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
           color:#C00000' lang=en-US><span style='font-weight:bold;font-family:
           微軟正黑體;font-size:11.0pt;color:black'>臨床表現</span><span
           style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：壞死區域呈</span><span
           style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>灰黑色、界線清楚</span><span
           style='font-family:微軟正黑體;font-size:11.0pt;color:black'>，可能</span><span
           style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>自動脫落（Autoamputation）</span></li>
      </ul>
      <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
       margin-bottom:0in'>
       <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
           color:#F79646' lang=en-US><span style='font-weight:bold;font-family:
           微軟正黑體;font-size:11.0pt;color:black'>治療</span></li>
       <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
        margin-bottom:0in'>
        <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
            color:#F79646' lang=en-US><span style='font-family:微軟正黑體;
            font-size:11.0pt;color:black'>嘗試保留肢體、血管重建；若保肢失敗，需手術截肢</span></li>
       </ul>
      </ul>
     </ul>
     <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
      margin-bottom:0in'>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
          lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;
          font-size:11.0pt;color:black'>濕性壞疽（Wet gangrene）</span></li>
      <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
       margin-bottom:0in'>
       <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
           color:#F79646' lang=en-US><span style='font-family:微軟正黑體;font-size:
           11.0pt;color:black'>因</span><span style='font-family:微軟正黑體;
           font-size:11.0pt;color:#C00000'>感染</span><span style='font-family:
           微軟正黑體;font-size:11.0pt;color:black'>惡化引起的壞死，病理表現為</span><span
           style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>凝固性與液化性壞死</span><span
           style='font-family:微軟正黑體;font-size:11.0pt;color:black'>（coagulative
           and liquefactive necrosis）</span></li>
       <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
           color:#F79646' lang=en-US><span style='font-weight:bold;font-family:
           微軟正黑體;font-size:11.0pt;color:black'>臨床表現</span><span
           style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：</span><span
           style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>水腫、水泡、有Discharge、外表濕潤</span></li>
       <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
           color:#F79646' lang=en-US><span style='font-weight:bold;font-family:
           微軟正黑體;font-size:11.0pt;color:black'>治療</span></li>
       <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
        margin-bottom:0in'>
        <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
            color:#C00000' lang=en-US><span style='font-family:微軟正黑體;
            font-size:11.0pt'>止痛、清創引流</span></li>
        <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
            color:#C00000' lang=en-US><span style='font-family:微軟正黑體;
            font-size:11.0pt'>廣效性抗生素</span></li>
       </ul>
       <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
        margin-bottom:0in'>
        <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
            color:#F79646' lang=en-US><span style='font-family:微軟正黑體;
            font-size:11.0pt;color:black'>局部感染受控後，才考慮血管重建</span></li>
        <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
            color:#F79646' lang=en-US><span style='font-family:微軟正黑體;
            font-size:11.0pt;color:black'>若保肢失敗，需手術截肢</span></li>
       </ul>
      </ul>
      <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
       margin-bottom:0in'>
       <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
           color:#C00000' lang=en-US><span style='font-weight:bold;font-family:
           微軟正黑體;font-size:11.0pt;color:black'>併發症</span><span
           style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：有機會演變成</span><span
           style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>敗血症</span></li>
      </ul>
     </ul>
    </ul>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>皮膚</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
         style='font-family:微軟正黑體;font-size:11.0pt'>溫度下降、出汗減少、乾燥萎縮、有光澤，可能呈現藍紫色變化</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
         style='font-family:微軟正黑體;font-size:11.0pt'>遠端毛髮減少（腿毛）</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
         style='font-family:微軟正黑體;font-size:11.0pt'>指甲生長變慢、變脆</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
         style='font-family:微軟正黑體;font-size:11.0pt'>肌肉萎縮</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt;color:#F79646'>網狀青斑（livedo reticularis）</span><span
         style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：PAD 晚期表現</span></li>
    </ul>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:#C00000'>脈搏減弱或消失</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:black'>，常見於：</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
         lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>肱動脈（brachial
         artery）</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
         lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>橈動脈（radial
         artery）</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
         lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>膕動脈（popliteal
         artery）</span></li>
    </ul>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>足背動脈（dorsalis
         pedis artery）</span></li>
    </ul>
   </ul>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt'>Buerger Sign</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>Bed-side測試，評估肢體灌流</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
         style='font-family:微軟正黑體;font-size:11.0pt'>請病人仰躺，將雙下肢抬高約 45
         度，觀察足部會否變蒼白。接著請病人坐起，讓雙腳垂下，觀察皮膚血色恢復及靜脈再膨起的時間</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt;color:#C00000'>陽性（Positive）</span><span style='font-family:
         微軟正黑體;font-size:11.0pt;color:black'>：嚴重缺血</span></li>
     <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
      margin-bottom:0in'>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>抬高肢體時足部蒼白</span></li>
     </ul>
     <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
      margin-bottom:0in'>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
          lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>垂足時出現反應性紅斑（reactive
          hyperemia）</span></li>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
          lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>靜脈再充盈時間
          &gt;20秒</span></li>
     </ul>
    </ul>
   </ul>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>血管雜音（Bruit）</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：在 </span><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>60-70%</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:black'> PAD患者身上可聽見</span></li>
   </ul>
  </ul>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
       lang=en-US><span style='font-family:微軟正黑體;font-size:14.0pt'>測量
       ABI（Ankle-Brachial Index）</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>ABI
        = 踝動脈收縮壓 / 肱動脈收縮壓（systolic ankle/brachial blood pressure）</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>何時測量 ABI</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt;color:#F79646'>懷疑PAD：有症狀</span><span style='font-family:微軟正黑體;
         font-size:11.0pt;color:black'>（跛行、休息疼痛、下肢有慢性傷口或壞疽）</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt;color:black'>高風險族群篩檢</span><span style='font-family:微軟正黑體;
         font-size:11.0pt;color:black'>（</span><span style='font-weight:bold;
         font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>糖尿病、吸菸、老年人</span><span
         style='font-family:微軟正黑體;font-size:11.0pt;color:black'>）</span></li>
    </ul>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>測量注意事項</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
         lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>病人須</span><span
         style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>平躺休息至少
         10 分鐘</span></li>
    </ul>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
         lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>測量</span><span
         style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>雙側腳踝</span><span
         style='font-family:微軟正黑體;font-size:11.0pt;color:black'>及</span><span
         style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>肱動脈壓</span></li>
     <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
      margin-bottom:0in'>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
          lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;
          font-size:11.0pt;color:black'>腳踝</span><span style='font-family:微軟正黑體;
          font-size:11.0pt;color:black'>：</span><span style='font-family:微軟正黑體;
          font-size:11.0pt;color:#C00000'>選 dorsalis pedis 或 posterior tibial
          中壓力較高者</span></li>
      <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
       margin-bottom:0in'>
       <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
           color:#C00000' lang=en-US><span style='font-family:微軟正黑體;font-size:
           11.0pt;color:black'>分別計算</span><span style='font-family:微軟正黑體;
           font-size:11.0pt;color:#C00000'>雙腳的 ABI</span></li>
      </ul>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
          lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;
          font-size:11.0pt;color:black'>肱動脈</span><span style='font-family:
          微軟正黑體;font-size:11.0pt;color:black'>：雙側</span><span style='font-weight:
          bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>取較高值</span></li>
     </ul>
    </ul>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>結果</span></li>
   </ul>
  </ul>
 </ul>
 <div style='direction:ltr'>
 <table border=1 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
  border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
  1pt;margin-left:.7083in' title="" summary="">
  <tr>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2F2F2;vertical-align:top;width:1.1625in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style='margin:0in;font-family:Calibri;font-size:11.0pt;text-align:center'><span
   style='font-weight:bold'>ABI 值</span></p>
   </td>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2F2F2;vertical-align:top;width:2.5708in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style='font-weight:bold'>表示</span></p>
   </td>
  </tr>
  <tr>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#DBEEF3;vertical-align:top;width:1.1625in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
   style='font-weight:bold'>&gt; 1.4</span></p>
   </td>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#DBEEF3;vertical-align:top;width:2.5708in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt'><span
   style='color:#C00000'>內膜鈣化性硬化（Medial calcific sclerosis）</span>，導致血管無法收縮</p>
   </td>
  </tr>
  <tr>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#EBF1DD;vertical-align:top;width:1.1625in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
   style='font-weight:bold'>1.0–1.4</span></p>
   </td>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#EBF1DD;vertical-align:top;width:2.5708in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
   style='font-weight:bold'>Normal</span></p>
   </td>
  </tr>
  <tr>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#FDEADA;vertical-align:top;width:1.1625in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
   style='font-weight:bold'>0.91–0.99</span></p>
   </td>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#FDEADA;vertical-align:top;width:2.5708in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
   style='font-weight:bold'>Borderline</span></p>
   </td>
  </tr>
  <tr>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2DCDB;vertical-align:top;width:1.1625in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
   style='font-weight:bold'>≤ 0.9</span></p>
   </td>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2DCDB;vertical-align:top;width:2.5708in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style='margin:0in;font-family:Calibri;font-size:11.0pt'><span
   style='font-weight:bold'>Abnormal</span></p>
   <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   color:#C00000'><span style='font-weight:bold'>（PAD confirmed）</span></p>
   </td>
  </tr>
 </table>
 </div>
 <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
      lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
      11.0pt;color:black'>下一步處置</span></li>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>全部病人</span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:black'>：</span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:#C00000'>Toe-Brachial Index, TBI</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>CLTI sign（-）</span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:black'>：</span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:#C00000'>Exercise ABI</span></li>
  </ul>
  <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>CLTI sign（+）</span><span style='font-family:微軟正黑體;
       font-size:11.0pt;color:black'>：</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>TcPO2</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：經皮氧氣分壓測量
        transcutaneous oximetry</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>SPP</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：皮膚灌流壓 skin
        perfusion pressure </span></li>
   </ul>
  </ul>
 </ul>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
      lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
      11.0pt;color:black'>運動後踝肱指數（Exercise ABI）</span></li>
  <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
       lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>在下肢進行</span><span
       style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>延長運動（extended
       exercise）</span><span style='font-family:微軟正黑體;font-size:11.0pt;
       color:black'>後測量ABI</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>適應症</span></li>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>懷疑PAD，但
        Rest ABI 結果正常或 Borderline</span></li>
   </ul>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:black' lang=en-US>確診
        PAD 且 ABI </span><span style='font-family:"Microsoft JhengHei Light";
        font-size:11.0pt;color:black' lang="x-IV_mathan">≤</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:black' lang=en-US>0.9，用以評估病患的功能狀態</span></li>
   </ul>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>確診條件</span></li>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>運動後</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>ABI下降超過20%</span></li>
   </ul>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>運動後</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>踝部收縮壓下降超過30
        mmHg</span></li>
   </ul>
  </ul>
 </ul>
 <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
      lang=en-US><span style='font-family:微軟正黑體;font-size:14.0pt'>影像檢查</span></li>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>適應症</span></li>
   <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt'>計劃接受血管重建手術</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt'>對PAD診斷有疑慮</span></li>
   </ul>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>檢查方式</span></li>
   <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>MR/CT/Catheter
        angiography </span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>雙功能超音波（Duplex
        ultrasound）</span></li>
    <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt;color:black'>確診 PAD</span><span style='font-family:微軟正黑體;
         font-size:11.0pt;color:black'>：</span><span style='font-family:微軟正黑體;
         font-size:11.0pt;color:#C00000'>收縮期峰值速度（peak systolic velocity, PSV）及
         PSV ratio 增加</span></li>
     <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
      margin-bottom:0in'>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
          lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;
          font-size:11.0pt;color:black'>PSV ratio</span><span style='font-family:
          微軟正黑體;font-size:11.0pt;color:black'>：</span><span style='font-weight:
          bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>病變處血流速度/鄰近正常動脈血流速度</span><span
          style='font-family:微軟正黑體;font-size:11.0pt;color:black'>；</span></li>
      <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
       margin-bottom:0in'>
       <li style='margin-top:0;margin-bottom:0;vertical-align:middle;
           color:#C00000' lang=en-US><span style='font-weight:bold;font-family:
           微軟正黑體;font-size:11.0pt;color:black'>&gt;2.5</span><span
           style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：病變處動脈</span><span
           style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;
           color:#F79646'>狹窄程度50–75%</span></li>
      </ul>
     </ul>
    </ul>
   </ul>
  </ul>
 </ul>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#244061'
      lang=en-US><span style='font-family:微軟正黑體;font-size:16.0pt'>處置/治療</span></li>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
       lang=en-US><span style='font-family:微軟正黑體;font-size:14.0pt'>原則</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:微軟正黑體;font-size:11.0pt'>控制粥樣動脈硬化的危險因子</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>戒菸</span><span
        style='font-family:微軟正黑體;font-size:11.0pt;color:black'>、結構化運動治療（Structured
        exercise therapy）</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>慢性 PAD：</span><span
        style='font-family:微軟正黑體;font-size:11.0pt'>抗血栓、傷口照護、考慮血管重建</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>CLTI：</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
         style='font-family:微軟正黑體;font-size:11.0pt'>患肢可保留 → 血管重建 </span></li>
    </ul>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
         lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>有生命威脅、敗血症
         → 考慮截肢</span></li>
    </ul>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>糖尿病足潰瘍無法癒合，可考慮</span><span
         style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>高壓氧（Hyperbaric
         oxygen therapy）</span></li>
    </ul>
   </ul>
  </ul>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
       lang=en-US><span style='font-family:微軟正黑體;font-size:14.0pt'>藥物治療</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>抗血栓</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt;color:#F79646'>有症狀的PAD</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
         style='font-weight:bold;font-family:"Microsoft JhengHei";font-size:
         11.0pt'>首選：</span></li>
     <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
      margin-bottom:0in'>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
          lang=en-US><span style='font-weight:bold;font-family:"Microsoft JhengHei";
          font-size:11.0pt;color:black'>單一抗血小板（</span><span style='font-weight:
          bold;font-family:Calibri;font-size:11.0pt;color:black'>Single
          antiplatelet therapy</span><span style='font-weight:bold;font-family:
          "Microsoft JhengHei";font-size:11.0pt;color:black'>）</span><span
          style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>：</span><span
          style='font-family:Calibri;font-size:11.0pt;color:#C00000'>Aspirin</span><span
          style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'>、</span><span
          style='font-family:Calibri;font-size:11.0pt;color:#C00000'>Clopidogrel</span><span
          style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:#C00000'>、</span><span
          style='font-family:Calibri;font-size:11.0pt;color:#C00000'>Ticagrelor</span></li>
     </ul>
     <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
      margin-bottom:0in'>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
          lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;
          font-size:11.0pt'>Low-dose Rivaroxaban + low-dose Aspirin</span></li>
     </ul>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt;color:black'>血管重建後</span><span style='font-family:微軟正黑體;
         font-size:11.0pt;color:black'>：</span><span style='font-family:微軟正黑體;
         font-size:11.0pt;color:#C00000'>雙抗血小板治療（Dual antiplatelet therapy）</span></li>
     <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
      margin-bottom:0in'>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
          lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>Aspirin +
          Clopidogrel</span></li>
     </ul>
    </ul>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>降血脂治療</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>所有PAD患者</span><span
         style='font-family:微軟正黑體;font-size:11.0pt;color:black'>皆應接受高強度 statin
         治療</span></li>
    </ul>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt;color:black'>極高風險ASCVD患者、statin效果不佳</span><span
         style='font-family:微軟正黑體;font-size:11.0pt;color:black'>：</span><span
         style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>加上 Ezetimibe
         ± PCSK9 inhibitor（alirocumab、evolocumab）</span></li>
    </ul>
   </ul>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>高血壓</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:black'>：首選 </span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:#C00000'>ACEi、ARB</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
         style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>目標</span><span
         style='font-family:微軟正黑體;font-size:11.0pt'>：</span><span
         style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>收縮壓
         &lt;130 mmHg；舒張壓 &lt;80 mmHg</span></li>
    </ul>
   </ul>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>糖尿病</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
         style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>建議</span><span
         style='font-family:微軟正黑體;font-size:11.0pt'>：</span><span
         style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>GLP-1 agonist
         與/或 SGLT-2 inhitbitor</span></li>
    </ul>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>間歇性跛行治療</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt;color:#C00000'>Cilostazol</span><span style='font-family:微軟正黑體;
         font-size:11.0pt;color:black'>：</span><span style='font-weight:bold;
         font-family:微軟正黑體;font-size:11.0pt;color:#F79646'>phosphodiesterase
         type 3 inhibitor</span></li>
     <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
      margin-bottom:0in'>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>血管擴張、抗血小板、抗血栓</span></li>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle'
          lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;
          color:#C00000'>可改善跛行症狀與步行距離，但無法降低重大心血管事件的發生率</span></li>
     </ul>
     <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
      margin-bottom:0in'>
      <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
          lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;
          font-size:11.0pt'>絕對禁忌症：任何程度之鬱血性心衰竭（congestive heart failure）</span></li>
     </ul>
    </ul>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>敗血症（sepsis）、濕性壞疽（Wet
        gangrene）</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
         lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>廣效性抗生素</span></li>
    </ul>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
         style='font-family:微軟正黑體;font-size:11.0pt'>會診外科評估是否需截肢</span></li>
    </ul>
   </ul>
  </ul>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
       lang=en-US><span style='font-family:微軟正黑體;font-size:14.0pt'>血管重建（Revascularization）</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>適應症</span></li>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
         lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:#C00000'>慢性肢體威脅性缺血（CLTI）：若患肢仍可保留</span></li>
    </ul>
    <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
         lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
         11.0pt;color:black'>慢性、有症狀 PAD：</span><span style='font-family:微軟正黑體;
         font-size:11.0pt;color:#C00000'>藥物及運動治療後仍無法改善</span></li>
    </ul>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>術式：</span><span
        style='font-family:微軟正黑體;font-size:11.0pt'>血管內、手術重建</span></li>
   </ul>
  </ul>
 </ul>
 <div style='direction:ltr'>
 <table border=1 cellpadding=0 cellspacing=0 valign=top style='direction:ltr;
  border-collapse:collapse;border-style:solid;border-color:#A3A3A3;border-width:
  1pt' title="" summary="">
  <tr>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2F2F2;vertical-align:top;width:.8395in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style='font-weight:bold'>類型</span></p>
   </td>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#FDEADA;vertical-align:top;width:2.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style='font-weight:bold'>血管內重建（Endovascular）</span></p>
   </td>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2DCDB;vertical-align:top;width:2.5152in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style='font-weight:bold'>手術血管重建（Surgical）</span></p>
   </td>
  </tr>
  <tr>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2F2F2;vertical-align:top;width:.7618in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style='font-weight:bold'>手術</span></p>
   </td>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#FDEADA;vertical-align:top;width:2.827in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <ul style='direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:
    0in'>
    <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'><span
         style='font-family:"Microsoft JhengHei";font-size:11.0pt'>經皮腔內血管擴張術（</span><span
         style='font-family:Calibri;font-size:11.0pt'>Percutaneous transluminal
         angioplasty, PTA</span><span style='font-family:"Microsoft JhengHei";
         font-size:11.0pt'>）</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'><span
         style='font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>合併</span><span
         style='font-weight:bold;font-family:"Microsoft JhengHei";font-size:
         11.0pt;color:black'>支架置放</span><span style='font-family:"Microsoft JhengHei";
         font-size:11.0pt;color:black'>與</span><span style='font-family:Calibri;
         font-size:11.0pt;color:black'>/</span><span style='font-family:"Microsoft JhengHei";
         font-size:11.0pt;color:black'>或</span><span style='font-weight:bold;
         font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>斑塊切除術（</span><span
         style='font-weight:bold;font-family:Calibri;font-size:11.0pt;
         color:black'>atherectomy</span><span style='font-weight:bold;
         font-family:"Microsoft JhengHei";font-size:11.0pt;color:black'>）</span></li>
    </ul>
   </ul>
   </td>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2DCDB;vertical-align:top;width:2.6784in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <ul style='direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:
    0in'>
    <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
         style='font-weight:bold;font-family:"Microsoft JhengHei";font-size:
         11.0pt'>周邊動脈繞道（</span><span style='font-weight:bold;font-family:Calibri;
         font-size:11.0pt'>Peripheral artery bypass surgery</span><span
         style='font-weight:bold;font-family:"Microsoft JhengHei";font-size:
         11.0pt'>）</span><span style='font-family:"Microsoft JhengHei";
         font-size:11.0pt'>：利用自體靜脈或人造材料進行繞道</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
         style='font-weight:bold;font-family:"Microsoft JhengHei";font-size:
         11.0pt'>動脈內膜切除術（</span><span style='font-weight:bold;font-family:Calibri;
         font-size:11.0pt'>Endarterectomy</span><span style='font-weight:bold;
         font-family:"Microsoft JhengHei";font-size:11.0pt'>）</span></li>
    </ul>
   </ul>
   </td>
  </tr>
  <tr>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2F2F2;vertical-align:top;width:.8041in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <p style='margin:0in;font-family:"Microsoft JhengHei";font-size:11.0pt;
   text-align:center'><span style='font-weight:bold'>適用症</span></p>
   </td>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#FDEADA;vertical-align:top;width:2.7562in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <ul style='direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:
    0in'>
    <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
         style='font-weight:bold;font-family:"Microsoft JhengHei";font-size:
         11.0pt'>狹窄</span><span style='font-weight:bold;font-family:Calibri;
         font-size:11.0pt'> &lt;10 cm </span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
         style='font-weight:bold;font-family:"Microsoft JhengHei";font-size:
         11.0pt'>阻塞</span><span style='font-weight:bold;font-family:Calibri;
         font-size:11.0pt'> &lt;5 cm</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
         style='font-weight:bold;font-family:"Microsoft JhengHei";font-size:
         11.0pt'>主動脈髂動脈病變（</span><span style='font-weight:bold;font-family:
         Calibri;font-size:11.0pt'>Aortoiliac</span><span style='font-weight:
         bold;font-family:"Microsoft JhengHei";font-size:11.0pt'>）</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
         style='font-weight:bold;font-family:"Microsoft JhengHei";font-size:
         11.0pt'>手術高風險患者</span></li>
    </ul>
   </ul>
   </td>
   <td style='border-style:solid;border-color:#A3A3A3;border-width:1pt;
   background-color:#F2DCDB;vertical-align:top;width:2.5812in;padding:2.0pt 3.0pt 2.0pt 3.0pt'>
   <ul style='direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:
    0in'>
    <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'><span
         style='font-family:"Microsoft JhengHei";font-size:11.0pt'>病變長：</span><span
         style='font-family:Calibri;font-size:11.0pt'>&gt;10 cm</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'><span
         style='font-family:"Microsoft JhengHei";font-size:11.0pt'>多處病灶</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'><span
         style='font-family:"Microsoft JhengHei";font-size:11.0pt'>股動脈病變</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'><span
         style='font-family:"Microsoft JhengHei";font-size:11.0pt'>膝下病變（</span><span
         style='font-family:Calibri;font-size:11.0pt'>infrapopliteal</span><span
         style='font-family:"Microsoft JhengHei";font-size:11.0pt'>）</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'><span
         style='font-family:"Microsoft JhengHei";font-size:11.0pt'>完全阻塞（</span><span
         style='font-family:Calibri;font-size:11.0pt'>total occlusion</span><span
         style='font-family:"Microsoft JhengHei";font-size:11.0pt'>）</span></li>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'><span
         style='font-family:Calibri;font-size:11.0pt'>Endovascular </span><span
         style='font-family:"Microsoft JhengHei";font-size:11.0pt'>失敗</span></li>
    </ul>
   </ul>
   </td>
  </tr>
 </table>
 </div>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
      style='font-family:微軟正黑體;font-size:14.0pt'>截肢</span></li>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>適應症</span></li>
   <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>濕性壞疽或患肢無法保留</span></li>
    <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
     margin-bottom:0in'>
     <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
         style='font-family:微軟正黑體;font-size:11.0pt'>合併敗血症可能需立即截肢</span></li>
    </ul>
   </ul>
   <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:black'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:#F79646'>乾性壞疽</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:black'>：先評估是否可行血管重建</span></li>
   </ul>
   <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>高風險CLTI或ALI患者且預後有限者
        </span></li>
   </ul>
   <ul type=square style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
        style='font-family:微軟正黑體;font-size:11.0pt'>血管重建成功後，可考慮階段性截除無法保留之組織</span></li>
   </ul>
  </ul>
 </ul>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#244061'
      lang=en-US><span style='font-family:微軟正黑體;font-size:16.0pt'>併發症</span></li>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
       lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
       11.0pt;color:black'>術後併發症</span></li>
   <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>Surgical</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:black'>：移植血管閉塞、感染、出血、死亡</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#F79646'
        lang=en-US><span style='font-weight:bold;font-family:微軟正黑體;font-size:
        11.0pt;color:black'>Endovascular</span><span style='font-family:微軟正黑體;
        font-size:11.0pt;color:black'>：血腫、假性動脈瘤、穿孔、遠端栓塞、血栓形成、再狹窄等</span></li>
   </ul>
  </ul>
 </ul>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#244061'
      lang=en-US><span style='font-family:微軟正黑體;font-size:16.0pt'>預後</span></li>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
       lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>CLTI
       患者心血管發病率和死亡率風險較高，5 年死亡率為 50%</span></li>
  </ul>
  <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
   margin-bottom:0in'>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-US><span
       style='font-weight:bold;font-family:微軟正黑體;font-size:11.0pt'>WIfI
       classification 不同期別 1 年內截肢率</span></li>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>Stage I：0%</span></li>
   </ul>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>Stage
        II：8%</span></li>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#366092'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt;color:black'>Stage
        III：11%</span></li>
   </ul>
   <ul type=disc style='direction:ltr;unicode-bidi:embed;margin-top:0in;
    margin-bottom:0in'>
    <li style='margin-top:0;margin-bottom:0;vertical-align:middle;color:#C00000'
        lang=en-US><span style='font-family:微軟正黑體;font-size:11.0pt'>Stage
        IV：38%</span></li>
   </ul>
  </ul>
 </ul>
 <ul type=circle style='direction:ltr;unicode-bidi:embed;margin-top:0in;
  margin-bottom:0in'>
  <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-GB><span
      style='font-weight:bold;font-family:Calibri;font-size:16.0pt'>Reference</span></li>
  <ol type=1 style='direction:ltr;unicode-bidi:embed;margin-top:0in;margin-bottom:
   0in;font-family:Calibri;font-size:11.0pt;font-weight:normal;font-style:normal'>
   <li value=1 style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-family:Calibri;font-size:11.0pt;font-weight:normal;
       font-style:normal;font-family:Calibri;font-size:11.0pt'>Sabiston
       Textbook of Surgery 21st Edition </span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-family:Calibri;font-size:11.0pt'>Schwartz's Principles of
       Surgery 11th Edition</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle' lang=en-GB><span
       style='font-family:Calibri;font-size:11.0pt'>Peripheral arterial
       disease, AMBOSS</span></li>
   <li style='margin-top:0;margin-bottom:0;vertical-align:middle'><span
       style='font-family:Calibri;font-size:11.0pt'>Conte MS, Bradbury AW, Kolh
       P, White JV, Dick F, Fitridge R, Mills JL, Ricco JB, Suresh KR, Murad
       MH, Aboyans V, Aksoy M, Alexandrescu VA, Armstrong D, Azuma N, Belch J,
       Bergoeing M, Bjorck M, Chakfé N, Cheng S, Dawson J, Debus ES, Dueck A,
       Duval S, Eckstein HH, Ferraresi R, Gambhir R, Gargiulo M, Geraghty P,
       Goode S, Gray B, Guo W, Gupta PC, Hinchliffe R, Jetty P, Komori K,
       Lavery L, Liang W, Lookstein R, Menard M, Misra S, Miyata T, Moneta G,
       Munoa Prado JA, Munoz A, Paolini JE, Patel M, Pomposelli F, Powell R,
       Robless P, Rogers L, Schanzer A, Schneider P, Taylor S, De Ceniga MV,
       Veller M, Vermassen F, Wang J, Wang S; GVG Writing Group for the Joint
       Guidelines of the Society for Vascular Surgery (SVS), European Society
       for Vascular Surgery (ESVS), and World Federation of Vascular Societies
       (WFVS). Global Vascular Guidelines on the Management of Chronic
       Limb-Threatening Ischemia. Eur J Vasc Endovasc Surg. 2019
       Jul;58(1S):S1-S109.e33. doi: 10.1016/j.ejvs.2019.05.006. Epub 2019 Jun
       8. Erratum in: Eur J Vasc Endovasc Surg. 2020 Mar;59(3):492-493. doi:
       10.1016/j.ejvs.2019.11.025. Erratum in: Eur J Vasc Endovasc Surg. 2020
       Jul;60(1):158-159. doi: 10.1016/j.ejvs.2020.04.033. PMID: 31182334;
       PMCID: PMC8369495.</span></li>
  </ol>
 </ul>
</ul>

</div>

</div>

</div>

<div>

<p style='margin:0in'>&nbsp;</p>

<p style='text-align:left;margin:0in;font-family:Arial;font-size:9pt;
color:#969696;direction:ltr'>使用 OneNote 建立。</p>

</div>

</body>

</html>